 Intralesional interferon treatment basal cell carcinoma Immunohistochemical study cellular immune reaction regression patients basal cell carcinomas intralesional injections interferon IU injection times week weeks Histopathologic examination biopsy specimens lesions absence basal cell carcinoma cases weeks completion therapy dense mononuclear cell infiltrate numerous ectatic blood vessels present dermis sites previous basal cell carcinoma Immunohistologic analysis dermal infiltrate marked increase cells slight predominance helper/inducer cells suppressor/cytotoxic cells dermal infiltrate HLA-DR antigen addition natural killer cells dermal infiltrate Immunohistologic changes skin lesions sites previous basal cell carcinoma intralesional interferon acts tumor cells enhancement local T-cell-mediated immune responses